Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Co-primary: • Compare progression-free survival (PFS) in patients treated with carfilzomib + filanesib and single-agent carfilzomib • Compare objective response rates (ORR) in patients with low serum alpha 1-acid glycoprotein (AAG) levels at Baseline treated with carfilzomib + filanesib and single-agent carfilzomib
Critère d'inclusion
- Multiple myeloma